3-TYP
目录号: PL11308 纯度: ≥99%
CAS No. :120241-79-4
商品编号 规格 价格 会员价 是否有货 数量
PL11308-5mg 5mg ¥741.82 请登录
PL11308-10mg 10mg ¥1236.36 请登录
PL11308-50mg 50mg ¥3709.09 请登录
PL11308-100mg 100mg ¥6058.18 请登录
PL11308-200mg 200mg 询价 询价
PL11308-500mg 500mg 询价 询价
PL11308-10mM*1mLinDMSO 10mM*1mLinDMSO ¥816.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
3-TYP
中文别名
3-(1H-1,2,3-噻唑-4-基)吡啶;吡啶-3-乙炔;3-(1H-1,2,3-三唑-5-基)吡啶
英文名称
3-TYP
英文别名
Pyridine,3-(1H-1,2,3-triazol-5-yl)-;3-(1H-1,2,3-Triazol-4-yl)pyridine;3-TYP;Pyridine, 3-(1H-1,2,3-triazol-4-yl)- (9CI);Pyridine(3-TYP);3-(1H-1,2,3-triazol-5-yl)pyridine;3-(1,2,3-triazol-4-yl)pyridine;3-(1H-1,2,3-triazol-4-yl) pyridine;Pyridine,3-(1H-1,2,3-triazol-4-yl)- (9CI);3-(2H-triazol-4-yl)pyridine;pyridin-3-yl-triazole;BDBM17471;VYXFEFOIYPNBFK-UHFFFAOYSA-N;BCP25686;4-(3-Pyridyl)-1,2,3-triazole;4-(3-Pyridinyl)-1H-1,2,3-triazole;AK204058;3-(2
Cas No.
120241-79-4
分子式
C7H6N4
分子量
146.15
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
3-TYP 是一种选择性的 SIRT3 抑制剂,IC50 值为 16 nM, 比对 SIRT1 和 SIRT2 的选择性强,IC50 值分别为 88 nM 和 92 nM。
生物活性
3-TYP is a selective SIRT3 inhibitor, with an IC 50 of 16 nM, more potent over SIRT1 (IC 50 =88 nM), SIRT2 (IC 50 =92 nM).
性状
Solid
IC50 & Target[1][2]
SIRT3 16 nM (IC50) SIRT1 88 nM (IC50
体外研究(In Vitro)
3-TYP inhibits melatonin-enhanced SIRT3 activity but does not affect SIRT3 protein expression. 3-TYP pretreatment reverses the protective effects of melatonin on cadmium (Cd)-induced mitochondrial-derived O2 production and autophagic cell death. 3-TYP significantly attenuates melatonin-induced increases in deacetylated-SOD2 expression and SOD2 activity in HepG2 cells exposed to Cd. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
3-TYP (50 mg/kg, i.p.) does not significantly influence the LVEF, LVFS, infarct size, serum LDH levels, apoptosis, and oxidative stress compared with those of the Sham group. Moreover, 3-TYP has little effect on gp91phox, Nrf2, NQO 1, Bax, Bcl-2, Caspase-3, and cleaved Caspase-3 expression levels, compared with the Sham group. 3-TYP significantly decreases SIRT3 activity and increases the acetylation of SOD2 compared with that in the control group, without influencing SIRT3 expression. 3-TYP attenuates the cardioprotective effects of melatonin by decreasing the LVEF and LVFS after 24 hour of reperfusion. 3-TYP also increases the infarct size, serum LDH levels, and apoptotic ratio compared with those in the IR+Mel group. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Pi H, et al. SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin. Autophagy. 2015;11(7):1037-51.
[2]. Zhai M, et al. Melatonin ameliorates myocardial ischemia reperfusion injury through SIRT3-dependent regulation of oxidative stress and apoptosis. J Pineal Res. 2017 Sep;63(2).
溶解度数据
In Vitro: DMSO : 125 mg/mL (855.29 mM; Need ultrasonic)Ethanol : 16.67 mg/mL (114.06 mM; Need ultrasonic)H2O : 1 mg/mL (6.84 mM; ultrasonic and warming and heat to 60°C)
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2